Announcements Trials
Browse Landscape

Phase

Phase 1 2

Status

Completed 156Recruiting 79Unknown 40Terminated 37Active not recruiting 26Withdrawn 12Not yet recruiting 5Available 4Suspended 2No longer available 1Enrolling by invitation 1

Sponsor Class

OTHER 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Gastrointestinal 17Gynecologic 2Genitourinary 2Breast 2Thoracic 1Sarcoma 1Head & Neck 1CNS 1

Conditions

Ovarian Neoplasms 12Uterine Cervical Neoplasms 7Endometrial Neoplasms 6Colorectal Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Peritoneal Neoplasms 3Neoplasms 3Neoplasm Metastasis 3Breast Neoplasms 3Vulvar Neoplasms 2Triple Negative Breast Neoplasms 2Prostatic Neoplasms 2Pancreatic Neoplasms 2Lung Neoplasms 2Fallopian Tube Neoplasms 2Carcinoma, Transitional Cell 2Carcinoma, Ovarian Epithelial 2Vulvar Diseases 1Uterine Neoplasms 1Tissue Adhesions 1Stomach Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Small Cell Lung Carcinoma 1Ovarian Cysts 1Osteosarcoma 1Obesity 1Mesothelioma, Malignant 1Melanoma 1Malnutrition 1Lichen Sclerosus et Atrophicus 1

Interventions

palbociclib 1gedatolisib 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Suspended × Pancreatic Neoplasms × Gynecologic × Clear all
NCT03065062 2026-02-13

Study of the CDK4/6 Inhibitor Palbociclib (PD-0332991) in Combination With the PI3K/mTOR Inhibitor Gedatolisib (PF-05212384) for Patients With Advanced Squamous Cell Lung, Pancreatic, Head & Neck and Other Solid Tumors

Dana-Farber Cancer Institute

Phase 1 Suspended
75 enrolled
GastrointestinalGynecologicHead & Neck

Head and Neck Neoplasms, Neoplasms, Pancreatic Neoplasms, Endometrial Neoplasms

NCT05958199 2025-06-27

A Study of NPX267 for Subjects With Solid Tumors Known to Express HHLA2/B7-H7

NextPoint Therapeutics, Inc.

Phase 1 Suspended
131 enrolled
BreastGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Carcinoma, Transitional Cell, Uterine Cervical Neoplasms, Neoplasm Metastasis, Pancreatic Neoplasms, Prostatic Neoplasms, Osteosarcoma, Colorectal Neoplasms, Endometrial Neoplasms, Cholangiocarcinoma, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡